We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
(+20%)
Cap. Flow
+$3.02B
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.43B |
| 2 |
Amazon
AMZN
|
+$601M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$414M |
| 4 |
D.R. Horton
DHI
|
+$305M |
| 5 |
Intel
INTC
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$905M |
| 2 |
NVIDIA
NVDA
|
+$592M |
| 3 |
Advanced Micro Devices
AMD
|
+$439M |
| 4 |
Amgen
AMGN
|
+$385M |
| 5 |
Adobe
ADBE
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 7.44% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Wrap Technologies
WRAP
$98.1M
| $92.4K | ﹤0.01% |
+29,810
| New | +$67.9K |
|
2027
Sagimet Biosciences
SGMT
$458M
| $91K | ﹤0.01% |
+16,785
| New | +$79.2K |
|
2028
AXT Inc
AXTI
$3.08B
| $85.7K | ﹤0.01% |
35,701
-20,496
| -36% | -$45.8K |
|
2029
1stdibs.com
DIBS
$154M
| $83.3K | ﹤0.01% |
+17,808
| New | +$75.1K |
|
|
VNET
2030
VNET Group
VNET
$2.04B
| $80.3K | ﹤0.01% |
+27,989
| New | +$84.2K |
|
2031
The Oncology Institute
TOI
$521M
| $80.1K | ﹤0.01% |
+39,282
| New | +$68.1K |
|
|
NVNO
2032
enVVeno Medical
NVNO
$7M
| $78.6K | ﹤0.01% |
+437
| New | +$69.6K |
|
2033
Traeger
COOK
$170M
| $75.6K | ﹤0.01% |
554
-306
| -36% | -$39.5K |
|
|
LDTCW
2034
CALL
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
| $74K | ﹤0.01% |
28,921
| – | – |
|
2035
Berkshire Hathaway Class B
BRK.B
$1.07T
| $72K | ﹤0.01% |
202
-150,638
| -100% | -$52.9M |
|
|
BKCC
2036
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $68.4K | ﹤0.01% |
17,671
+985
| +6% | +$3.58K |
|
|
AISPW
2037
CALL
Airship AI Holdings Warrants
AISPW
$15.6M
| $68K | ﹤0.01% |
40,000
-8,965
| -18% | -$706 |
|
|
EBIX
2038
DELISTED
Ebix Inc
EBIX
| $67.7K | ﹤0.01% |
65,127
-336,805
| -84% | -$1.69M |
|
2039
Black Diamond Therapeutics
BDTX
$102M
| $64.4K | ﹤0.01% |
+22,924
| New | +$53.8K |
|
2040
Heritage Global
HGBL
$42.4M
| $64.4K | ﹤0.01% |
23,160
-21,258
| -48% | -$62.6K |
|
2041
ICL Group
ICL
$6.63B
| $62.1K | ﹤0.01% |
+12,400
| New | +$63.1K |
|
2042
Playboy Inc
PLBY
$144M
| $61.8K | ﹤0.01% |
61,791
-39,290
| -39% | -$25.8K |
|
2043
Tenaya Therapeutics
TNYA
$168M
| $61.4K | ﹤0.01% |
+18,941
| New | +$40.9K |
|
2044
InflaRx
IFRX
$252M
| $58.7K | ﹤0.01% |
36,001
+23,500
| +188% | +$40.3K |
|
|
MSPR
2045
DELISTED
MSP Recovery Inc
MSPR
| $57.4K | ﹤0.01% |
144
| – | – |
|
2046
Altisource Portfolio Solutions
ASPS
$63.4M
| $54.7K | ﹤0.01% |
1,920
+413
| +27% | +$13.1K |
|
|
YRD
2047
Yiren Digital
YRD
$103M
| $54.1K | ﹤0.01% |
+17,327
| New | +$45.5K |
|
2048
Standard BioTools
LAB
$311M
| $51.9K | ﹤0.01% |
23,472
| – | – |
|
2049
ECARX Holdings
ECX
$421M
| $51.5K | ﹤0.01% |
16,301
-2,407
| -13% | -$7.9K |
|
|
AERT
2050
Aeries Technology
AERT
$38.7M
| $48.5K | ﹤0.01% |
+2,426
| New | +$109K |
|
Similar funds
Marshall Wace's Q4 2023 Portfolio in Review
As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.
- Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
- Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
- Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
- Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
- Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
- Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.